Research Article
The Effectiveness of Myo-Inositol and D-Chiro Inositol Treatment in Type 2 Diabetes
Table 2
Clinical changes between baseline and three months after starting inositol treatment.
| | | Baseline | 3 months | |
| | Weight (kg) | 80.5 ± 17.7 | 79.8 ± 15.8 | 0.14 | | BMI (Kg/m2) | 31.1 ± 5.9 | 30.9 ± 6.6 | 0.14 | | Classes of BMI (%): | | | 0.34 | | <25 Kg/m2 | 15.4 | 20.0 | | | 25–29 Kg/m2 | 23.1 | 10.0 | | | ≥30 Kg/m2 | 61.5 | 70.0 | | | Systolic blood pressure (mmHg) | 126.7 ± 10.8 | 124.4 ± 9.5 | 0.10 | | Diastolic blood pressure (mmHg) | 75.0 ± 7.7 | 76.1 ± 5.5 | 0.90 | | Fasting blood glucose levels (mg/dl) | 192.6 ± 60.2 | 160.9 ± 36.4 | 0.02 | | HbA1c (%) | 8.6 ± 0.9 | 7.7 ± 0.9 | 0.02 | | Total cholesterol (mg/dl) | 189.3 ± 39.5 | 198.7 ± 38.8 | 0.31 | | HDL cholesterol (mg/dl) | 57.3 ± 19.6 | 50.6 ± 10.1 | 0.89 | | Triglycerides (mg/dl) | 161.5 ± 131.1 | 149.9 ± 64.4 | 0.61 | | LDL cholesterol (mg/dl) | 98.9 ± 36.1 | 116.4 ± 43.7 | 0.69 |
|
|
